Dulaglutide
Also known as: Trulicity
Status
FDA-approved. Approved since 2014 (Trulicity, type 2 diabetes).
What it is
A once-weekly GLP-1 agonist built as a peptide fused to an antibody fragment — a different structural trick from semaglutide's fatty-acid anchor, aimed at the same receptor.
Source
FDA prescribing information (Trulicity)
Sources
Educational use only, never medical advice. No doses.